Kumar Dilip Ashtekar

MedicineMaterials ScienceChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations”.

Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations

Nature Communications(2022)10.1038/s41467-022-34398-z

N/A

0.584DataRank · unranked

48 citations

David Lu, Michael J. Grant, Steven E. Stayrook, Manali Phadke, Zenta Walther +6 more

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

Cancer Research(2020)10.1158/0008-5472.can-19-3819

N/A

0DataRank · unranked

60 citations

Alexis Guernet, Maria Emanuela Cuomo, Kamrine E. Poels, Iris K. van Alderwerelt van Rosenburgh, Amy Nagelberg +19 more

Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes

Cell Reports(2023)10.1016/j.celrep.2023.113603

N/A

0DataRank · unranked

40 citations

Eric Burns, David J. Schodt, Zaritza O. Petrova, Anatoly Kiyatkin, Lucy W. Kim +9 more

Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor

Cell chemical biology(2023)10.1016/j.chembiol.2023.09.013

N/A

0DataRank · unranked

24 citations

Jaweria Bakar, Surbhi P. Chitnis, Erin L. Sausville, Kumar Dilip Ashtekar, Brianna E. Mendelson +5 more

Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.10.536273

N/A

0DataRank · unranked

2 citations

Eric Burns, David J. Schodt, Zaritza O. Petrova, Anatoly Kiyatkin, Lucy W. Kim +9 more

A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition

npj Precision Oncology(2024)10.1038/s41698-023-00490-w

N/A

0DataRank · unranked

4 citations

Zaritza O. Petrova, Lisa Hunihan, Kumar Dilip Ashtekar, Zenta Walther, Frederick H. Wilson +1 more